Sepsis and Vitamin D Flashcards
what is sepsis?
In a NORMAL response to an infection, the inflammatory and coagulation response is localized to the infection site as the immune system attacks the pathogen, eliminating it from the body
Sepsis: The inflammatory and coagulation response is rapid and widespread, causing a dysregulated response.
- The body’s reaction to the pathogen may overwhelm all of the body’s systems - cause multi-organ failure
- Immune systems that are too strong or too weak are unable to respond effectively to pathogen invasion
- Dysregulated inflammation where both pro and anti-inflammatory mechanisms overlap
- Heart failure, kidney failure, delirium and death
what are the common causes of sepsis?
Bacterial infections are the most common e.g. Staph aureus, E. coli, strep infections
- Fungal, parasitic or viral (flu) infections can also cause sepsis
- The infection can originate from anywhere in the body and can cause organ damage to any system of the body
- Unknown – in ~1/3 of cases with sepsis the infectious cause is not identified
what are the common sites of infection in sepsis?
35% lung infection pneumonia
25% UTI
11% gut infection
CNS is rare
Any infected organ can cause sepsis
out of infected and really sick patients, how many are septic?
only a very small proportion
- A proportion of those infected or really sick are septic
- Not all patients are septic
how does pneumonia progress?
pneumonia progresses from lung infection to get sepsis if not treated quickly, then severe sepsis, then septic shock/acute respiratory distress syndrome
- these stages see increasing mortality = higher severity, increased risk of death
- in elderly, 20% mortality with pneumonia, 50% with septic shock
definition of sepsis?
life threatening organ dysfunction caused by a dysregulated host response to infection
Episode of sepsis ages the immune system which cant be recovered
what is SIRS and CARS?
systemic immune response syndrome (SIRS)
- highly pro-inflammatory - exaggerated inflammation
compensatory anti-inflammatory response syndrome (CARS)
- suppress inflammation
- some immune cells underactive
these two angles of sepsis overlap and are difficult to control
how does sepsis induce immunosuppression?
- decrease in the number of T cells (helper and cytotoxic) due to apoptosis and a decreased response to inflammatory cytokines e.g. LPS resistance
- Decreased production of crucial cytokines such as IL-6 and TNF in response to endotoxin.
- neutrophils express fewer chemokine receptors, and there was diminished chemotaxis in response to IL-8 - lack targeted migration
- immune system in a septic individual is unable to stage an effective immune response to secondary bacterial, viral, or fungal infections.
- A low lymphocyte count early in sepsis (day 4 of diagnosis) is predictive of both 28-day and 1-year mortality, it has been postulated that early lymphopenia can serve as a biomarker for immunosuppression in sepsis.
- severe lymphopenia seen in 40% of COVID cases
what organs can be involved in sepsis?
- Circulation: Hypotension, increases in microvascular permeability
- Lung - ARDS: Pulmonary Edema, hypoxemia
- GI tract: Translocation of bacteria from gut, Liver Failure
- Nervous System:Encephalopathy, Critical Illness Polyneuropathy
- Hematologic: DIC – clotting system is dysregulated with bleeding and clotting, coagulopathy
- Kidney: Acute Tubular Necrosis, acute renal failure
disease in every organ
is sepsis a major worldwide healthcare problem? why?
yes: Affecting an estimated 30 million adults and children each year resulting in potentially 6 million deaths annually
- Accounts for ~20% of hospital admissions but is a factor in over 50% of hospital deaths
- Is the leading cause of hospital readmissions (25% within 6 months)
- Although mortality has decreased in the last decade, it remains over 25 percent → 1 in 4 people die
- After sepsis for 90 days increased risk of CVD events
how does sepsis kill?
SIRS leads to release of pro-inflammatory cytokines e.g. TNF, I-1, IL-6 - systemic inflammatory response
- then release of DAMPs e.g. HMGB1
- dysregulated CARS
- complement activation
- coagulopathy
- loss of vascular integrity which can lead to apoptosis, vasoactive peptide release e.g. VEGF, ANG1
what evidence is there of a dysregulated immune response in sepsis?
Evidence of hyperinflammation
- netosis, cytokines, endothelial injury, loss of barrier function, thrombosis
Enidence of immunosuppression
- T cell exhaustion
why is the endothelium important in immune responses
Upon inflammation/infection, there is release of mediators of vasodilatation and/or vasoconstriction
- Release of cytokines and inflammatory mediators
- Allows leukocytes to access infection sites
- Plays an important role in the coagulation cascade, maintaining the physiological equilibrium between coagulation and fibrinolysis
- clots can prevent too many inflammatory cells entering tissues
how is the endothelium dysregulated in sepsis?
In sepsis, the regulatory function of the endothelium fails, leading to:
- Excessive vasodilation and relative hypovolaemia
- Leaking capillaries which drive generalised tissue damage
- Tissue factor (TF) release initiates procoagulant state
- Micro-thrombus formation compromising blood supply and leading to tissue necrosis
- Inactivation of Protein C and suppression of fibrinolysis
Refractory vasodilation control is lost. Tissue injury and clot formation is dysregulated
what patients are at risk for sepsis?
Patients with bacteria+ blood cultures - circulating bugs in blood
Comorbidities causing host-defense depression: AIDS, renal or liver failure, neoplasms (cancer), neutropenia
very young (neonates) and elderly (>75)
Alcohol, drug abusers, smokers
Severe Vitamin D deficiency
Often in haemotalogy and oncology patients
Pre-sepsis: Immune status affected by comorbidities, age, genetics, microbiome
how is sepsis treated?
Many infusion pumps
Ventilator
Renal replacement therapy machine
The more pumps needed, the worse prognosis
Treatment:
Early antibiotic therapy
Fluids – keep blood pressure up with IV saline
Careful monitoring – intervene with renal impairment, look for signs of organ failure
Organ support - ventilation, renal replacement therapy due to acute kidney injury
are there specific therapies for sepsis?
No specific drug for patient with sepsis
Sepsis is heterogenous
Hard to target one thing
what are the basic principles of immunomodulatory therapies in sepsis?
- anti-inflammatory therapy should do as little damage to immune function as possible - shouldn’t be too string
- immune enhancement therapy should avoid inflammatory rebound as much as possible e.g. GM-CSF to improve cellular function, but shouldn’t cause too much rebound inflammation to drive bystander tissue damage
- Neutrophils are abnormal in sepsis – dysregulated chemotaxis, apoptosis - Need mild drug to restore neutrophil function to normal
- The goal of immunotherapy should be to curb the excessive but retain moderate inflammatory; repair of the deep immunosuppression should allow retaining moderate
what therapies have failed in sepsis?
Corticosteroids—high dose methylprednisolone
Anti-endotoxin antibodies
TNF antagonists—soluble TNF receptor - By the time a person has sepsis, TNF isn’t that high
- Most circularitng TNF signal is switched off, so anti-TNF doesn’t work
Ibuprofen, non-steroidal anti-inflammatories
why have trials failed?
The experimental agents are ineffective.
Doses of experimental agents are inadequate
Timing of intervention is inadequate
Patient population is to heterogeneous
how have experimental agents been ineffective?
e.g anti-endotoxin agents HA-1A and E5 were supposed to bind to the lipid A portion of endotoxin and neutralize endotoxin activity
- in vitro testing showed that neither of these compounds were able to limit endotoxin activity or to reduce the release of IL-1 or TNF
- Anti-endotoxin wasn’t stopping the bioactivity of endotoxin
how have doses of experimental agents been inadequate?
Poor PK (pharmacokinetics /dynamics) testing in sepsis patients rather than normal controls
- PK tests were done in healthy people – not as applicable for patients as they are heterogeneous
- liver and renal dysfunction, altered carrier protein levels, poor perfusion, hypoxia, microthrombosis in patients - this means different absorption, plasma levels and tissue penetration of drug
how is timing of intervention inadequate?
TNF and IL-1 are released early in the course of sepsis, and then falls back down; thus, there is a narrow window of opportunity for effective treatment.
In contrast HMGB-1 is released later in the septic process and are sustained to drive organ failure.
Anti-TNF agent given late on likely won’t work
Maybe shouldn’t focus on acute cytokine release
how is the patient population too heterogeneous?
Patients with sepsis are a mixed group in terms aetiology - different bacteria causing sepsis
Have diverse ages, present with diverse underlying conditions
They have sepsis caused by various organisms and from different sites and origins.
Maybe focus on single aetiology e.g. those with pneumonia vs those with inflammation in gut